Avicanna Announces US Patent and Trademark Office Issuance of New Patent

USPTO Issues Patent No. US 12,343,315 B2 covering topical cannabinoid compositions for clear skin

TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce that the USPTO has issued a patent covering Avicanna’s topical cannabinoid compositions for clear skin.

Read more at globenewswire.com